Nalan Gundogdu-Karaburun
Anadolu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nalan Gundogdu-Karaburun.
Farmaco | 2002
Şeref Demirayak; Ümit Uçucu; Kadriye Benkli; Nalan Gundogdu-Karaburun; Ahmet Cagri Karaburun; Derya Akar; Muhammed Karabacak; Nuri Kiraz
In this study, some aryl(benzofuran-2-yl)ketoximes and their ethers and esters were synthesised. The structure elucidation of the compounds was performed by IR, 1H NMR and mass spectroscopic data and elemental analyses results. Antifungal activities of the compounds were examined and notable activity was obtained.
Journal of Enzyme Inhibition and Medicinal Chemistry | 2015
Seref Demirayak; Leyla Yurttaş; Nalan Gundogdu-Karaburun; Ahmet Cagri Karaburun; Ismail Kayagil
Abstract In this study, we have synthesized 2-[3- or 4-(2-aryl-2-oxoethoxy)arylidene]benzofuran-3-one derivatives (D1–D38) and evaluated their anti-cancer activities. The final compounds were obtained in multistep synthesis reactions using benzofuranon-3-one derivatives (A1–A4, B) as starting materials which were gained in various synthetic ways. Aurone derivatives (C1–C10) were acquired with the condensation reaction of these starting materials and 3-/4-hydroxybenzaldehyde which were then reacted with α-bromoacetophenones to get final compounds. The anti-cancer activity of the selected compounds was performed by National Cancer Institute (NCI), USA against 60 human tumor cell lines derived from nine neoplastic diseases. Compounds exhibited anti-cancer activity in varying ratios.
Journal of The Saudi Pharmaceutical Society | 2017
Seref Demirayak; Leyla Yurttaş; Nalan Gundogdu-Karaburun; Ahmet Cagri Karaburun; Ismail Kayagil
The synthesis of 3-[3/4-(2-aryl-2-oxoethoxy)arylidene]chroman/thiochroman-4-one derivatives (1–34) and evaluation of their anticancer activities were aimed in this work. Final compounds were obtained in multistep synthesis reactions using phenol/thiophenol derivatives as starting materials. For anticancer activity evaluation, all compounds were offered to National Cancer Institute (NCI), USA and selected ones were tested against sixty human tumor cell lines derived from nine neoplastic diseases. The activity results were evaluated according to the drug screening protocol of the institute. Compounds containing thiochromanone skeleton exhibited higher anticancer activity.
European Journal of Medicinal Chemistry | 2006
Nalan Gundogdu-Karaburun; Kadriye Benkli; Yağmur Tunalı; Ümit Uçucu; Şeref Demirayak
Letters in Drug Design & Discovery | 2011
Ahmet Cagri Karaburun; Zafer Asım Kaplancıklı; Nalan Gundogdu-Karaburun; Fatih Demirci
Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry | 2004
Kadriye Benkli; Seref Demirayak; Nalan Gundogdu-Karaburun; Nuri Kiraz; Gökalp İşcan; Ümit Uçucu
Letters in Drug Design & Discovery | 2014
Nalan Gundogdu-Karaburun
Letters in Drug Design & Discovery | 2014
Nalan Gundogdu-Karaburun; Ahmet Cagri Karaburun; Seref Demirayak; Ismail Kayagil; Leyla Yurttaş
Letters in Drug Design & Discovery | 2011
Ahmet Cagri Karaburun; Nalan Gundogdu-Karaburun; Ümit Uçucu; Seref Demirayak
Letters in Drug Design & Discovery | 2016
Seref Demirayak; Leyla Yurttaş; Ahmet Cagri Karaburun; Nalan Gundogdu-Karaburun; Ismail Kayagil